Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?

Magdalena Meszaros; José Ursic‐bedoya; Stéphanie Faure; Georges‐philippe Pageaux

doi:10.1002/hep.30345

Retour

Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?

Article de revue

Avec comité de lecture

Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?

Magdalena Meszaros, José Ursic‐bedoya, Stéphanie Faure et Georges‐philippe Pageaux

Hepatology, Vol.69(5), pp.2302-2303

05/2019

DOI: https://doi.org/10.1002/hep.30345

PMID: 30394549

Résumé

We have read with great interest the article by Jucaud et al. (1) reporting that de novo donor-specific HLA antibodies (dnDSA) development during immunosuppression (IS) withdrawal in liver transplantation (LT) was associated with acute rejection and prevented further attempts of IS withdrawal.

Fichiers et liens (1)

url

Find in HALAfficher

Indicateurs

1 Consultations de la notice

Détails

Titre: Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?
Créateurs - sans rôle: Magdalena Meszaros - Hôpital Saint Eloi
José Ursic‐bedoya - Centre Hospitalier Universitaire de Montpellier
Stéphanie Faure - Hôpital Saint Eloi
Georges‐philippe Pageaux - Institute for Regenerative Medicine & Biotherapy
Détails de publication: Hepatology, Vol.69(5), pp.2302-2303
Identifiants: 99153028909311
Unité académique: Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
Langue: English
Type de ressource: Journal article
Champs locaux: hal-02563429